Cargando…

Digital ischemic events related to gemcitabine: Report of two cases and a systematic review

BACKGROUND: Gemcitabine is a potent cytotoxic agent used in the treatment of many solid tumours, sarcomas and lymphomas. Vascular toxicity and thrombotic events related to gemcitabine seem to be underreported. CASE REPORT: We report two cases of gemcitabine related digital ischemic events. Case 1. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhar, Cvetka Grasic, Mesti, Tanja, Zakotnik, Branko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita, Warsaw 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423709/ https://www.ncbi.nlm.nih.gov/pubmed/22933925 http://dx.doi.org/10.2478/v10019-010-0020-1

Ejemplares similares

Effectiveness of adjuvant trastuzumab in daily clinical practice
por: Matos, Erika, et al.
Publicado: (2014)

Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors
por: Mesti, Tanja, et al.
Publicado: (2023)

Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a case report
por: Grasic Kuhar, Cvetka, et al.
Publicado: (2014)

The Biology and Clinical Potential of Circulating Tumor Cells
por: Lozar, Taja, et al.
Publicado: (2019)

Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
por: Besic, Nikola, et al.
Publicado: (2021)

Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer
por: Kuhar, Cvetka Grašič, et al.
Publicado: (2023)

Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population
por: Grasic Kuhar, Cvetka, et al.
Publicado: (2023)

Morphological Features of Breast Cancer Circulating Tumor Cells in Blood After Physical and Biological Type of Isolation
por: Jesenko, Tanja, et al.
Publicado: (2021)

Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer
por: Grašič Kuhar, Cvetka, et al.
Publicado: (2023)

Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study
por: Grašič Kuhar, Cvetka, et al.
Publicado: (2020)

Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer
por: Lozar, Taja, et al.
Publicado: (2020)

Neuroendocrine Carcinoma of the Larynx and Pharynx: A Clinical and Histopathological Study
por: Strojan, Primož, et al.
Publicado: (2021)

The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
por: Miceska, Simona, et al.
Publicado: (2023)

The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy
por: Geršak, Klara, et al.
Publicado: (2023)

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results of the CECOG LaVie trial
por: Thallinger, Christiane, et al.
Publicado: (2016)

Adverse Events During Immunotherapy in Slovenian Patients with Metastatic Melanoma Reveal a Positive Correlation with Better Treatment Outcomes
por: Mesti, Tanja, et al.
Publicado: (2021)

A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
por: Matos, Erika, et al.
Publicado: (2016)

The Five-year KRAS, NRAS and BRAF Analysis Results and Treatment Patterns in Daily Clinical Practice in Slovenia in 1(st) Line Treatment of Metastatic Colorectal (mCRC) Patients with RAS Wild-type Tumour (wtRAS) – A Real- Life Data Report 2013–2018
por: Mesti, Tanja, et al.
Publicado: (2023)

Malignant gliomas: old and new systemic treatment approaches
por: Mesti, Tanja, et al.
Publicado: (2016)

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe: An initiative of the Central European Cooperative Oncology Group (CECOG)
por: Thallinger, Christiane, et al.
Publicado: (2022)

Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia
por: Mesti, Tanja, et al.
Publicado: (2022)

Trends in Population-based Cancer Survival in Slovenia
por: Zadnik, Vesna, et al.
Publicado: (2021)

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
por: Fiteni, Frédéric, et al.
Publicado: (2014)

Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy
por: Soba, Erika, et al.
Publicado: (2015)

Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience
por: Chiru, E.D., et al.
Publicado: (2023)

Molecular Biomarkers and Histological Parameters Impact on Survival and Response to First- Line Systemic Therapy of Metastatic Colorectal Cancer Patients
por: Rebersek, Martina, et al.
Publicado: (2019)

Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
por: Marinko, Tanja, et al.
Publicado: (2014)

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Li, Doudou, et al.
Publicado: (2015)

Response of follicular dendritic cell sarcoma to gemcitabine and docetaxel: report of two cases and literature review
por: Conry, Robert M
Publicado: (2014)

Gemcitabine-Related Acute Coronary Syndrome
por: Hazam, Randa, et al.
Publicado: (2020)

Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond
por: Lozar, Taja, et al.
Publicado: (2023)

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma
por: So, Eiichiro, et al.
Publicado: (2017)

Gemcitabine and taxanes in metastatic breast cancer: a systematic review
por: Gudena, Vinay, et al.
Publicado: (2008)

Prolonged low-dose infusion for gemcitabine: a systematic review
por: Zhao, Dehua, et al.
Publicado: (2019)

Cisplatin/gemcitabine: Pancytopenia: case report
Publicado: (2021)

Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours
por: Bombac, Alenka, et al.
Publicado: (2020)

Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas
por: Nassif, Elise F., et al.
Publicado: (2023)

The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement
por: Mesti, Tanja, et al.
Publicado: (2015)

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
por: Mesti, Tanja, et al.
Publicado: (2015)

Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report
por: Kiraly, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_obn67dapk1b4jcmds0rupla566